|
Correlation
between SCP-1 expression and clinico-pathological features
in epithelial ovarian cancer.
|
Pathological
and Clinical Features
|
No.
of Patients
|
|
SCP-1
Positive
|
SCP-1
Negative
|
|
All
tumors (n=100)
|
15
(15%)
|
85
(85%)
|
|
Age
(median, range)
|
68
(68, 46-86)
|
61
(62, 22-88 yrs)
|
|
Tumor
grade:
|
1
|
-
|
6
|
2
|
4
|
5
|
3
|
11
|
74
|
|
FIGO
stage:
|
Ia
|
1
|
3
|
Ib
|
-
|
1
|
Ic
|
-
|
3
|
IIb
|
-
|
2
|
IIc
|
-
|
4
|
IIIa
|
-
|
1
|
IIIb
|
-
|
2
|
IIIc
|
13
|
63
|
IV
|
1
|
6
|
|
Histology:
|
Papillary
serous
|
13
|
60
|
Clear
cell
|
-
|
6
|
Endometrioid
|
-
|
5
|
Mucinous
|
-
|
2
|
Undifferentiated
|
-
|
3
|
Other
(transitional, mixed, carcinosarcoma)
|
1
|
9
|
|
Response:
|
Complete response
|
7 (47%)
|
45 (53%)
|
Partial response
|
7 (47%)
|
33 (39%)
|
|
Total Recurrences/Persistent disease
|
9 (60%)
|
52 (61%)
|
|
Died of disease
|
9 (60%)
|
22 (26%)
|
|
Alive with disease
|
2 (13%)
|
29 (34%)
|
|
Alive with no evidence of disease
|
3 (20%)
|
32 (38%)
|
|
